These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 27384733)
81. A polymeric form of fibronectin has antimetastatic effects against multiple tumor types. Pasqualini R; Bourdoulous S; Koivunen E; Woods VL; Ruoslahti E Nat Med; 1996 Nov; 2(11):1197-203. PubMed ID: 8898745 [TBL] [Abstract][Full Text] [Related]
82. Precise and Facile Endotracheal Lung-tumor-implantation Mouse Model Visualized by GFP Expression. Aoki Y; Kobayashi KJ; Varshney N; Kubota Y; Masaki N; Obara K; Wang JD; Tome Y; Bouvet M; Nishida K; Hoffman RM In Vivo; 2023; 37(4):1477-1481. PubMed ID: 37369517 [TBL] [Abstract][Full Text] [Related]
83. Population pharmacokinetics of bevacizumab in children with osteosarcoma: implications for dosing. Turner DC; Navid F; Daw NC; Mao S; Wu J; Santana VM; Neel M; Rao B; Willert JR; Loeb DM; Harstead KE; Throm SL; Freeman BB; Stewart CF Clin Cancer Res; 2014 May; 20(10):2783-92. PubMed ID: 24637635 [TBL] [Abstract][Full Text] [Related]
84. Effect of ascorbic acid, lysine, proline, and green tea extract on human osteosarcoma cell line MNNG-HOS xenografts in nude mice: evaluation of tumor growth and immunohistochemistry. Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M Med Oncol; 2006; 23(3):411-7. PubMed ID: 17018899 [TBL] [Abstract][Full Text] [Related]
85. Does memantine show chemopreventive effect against mice 4T1 breast tumor model? Albayrak G; Bali EB; Korkmaz FD; Bağrıaçık EÜ Turk J Med Sci; 2022 Jun; 52(3):841-847. PubMed ID: 36326318 [TBL] [Abstract][Full Text] [Related]
86. Efficient and Consistent Orthotopic Osteosarcoma Model by Cell Sheet Transplantation in the Nude Mice for Drug Testing. Wu H; He Z; Li X; Xu X; Zhong W; Bu J; Huang G Front Bioeng Biotechnol; 2021; 9():690409. PubMed ID: 34631675 [TBL] [Abstract][Full Text] [Related]
87. Fluorescence Detection of Cell Death in Liver of Mice Treated with Thioacetamide. Kang JS Toxicol Res; 2018 Jan; 34(1):1-6. PubMed ID: 29371995 [TBL] [Abstract][Full Text] [Related]
89. Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model. Masuda C; Sugimoto M; Wakita D; Monnai M; Ishimaru C; Nakamura R; Kinoshita M; Yorozu K; Kurasawa M; Kondoh O; Yamamoto K Clin Exp Metastasis; 2020 Feb; 37(1):199-207. PubMed ID: 31768815 [TBL] [Abstract][Full Text] [Related]
90. Targeted anti-angiogenesis therapy for advanced osteosarcoma. Zhang Q; Xia Y; Wang L; Wang Y; Bao Y; Zhao GS Front Oncol; 2024; 14():1413213. PubMed ID: 39252946 [TBL] [Abstract][Full Text] [Related]
91. Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality. Yu L; Zhang J; Li Y Front Immunol; 2022; 13():871076. PubMed ID: 36311748 [TBL] [Abstract][Full Text] [Related]
92. Bevacizumab attenuates osteosarcoma angiogenesis by suppressing MIAT encapsulated by serum-derived extracellular vesicles and facilitating miR-613-mediated GPR158 inhibition. Wang BD; Yu XJ; Hou JC; Fu B; Zheng H; Liu QK; Wang SX; Bi ZG; Cao Y Cell Death Dis; 2022 Mar; 13(3):272. PubMed ID: 35347106 [TBL] [Abstract][Full Text] [Related]
93. Circular RNA circFOXP1 promotes angiogenesis by regulating microRNA -127-5p/CDKN2AIP signaling pathway in osteosarcoma. Zhang H; Yu Z; Wu B; Sun F Bioengineered; 2021 Dec; 12(2):9991-9999. PubMed ID: 34637672 [TBL] [Abstract][Full Text] [Related]
94. Anti-Angiogenic Treatments Interact with Steroid Secretion in Inflammatory Breast Cancer Triple Negative Cell Lines. Alonso-Diez Á; Cáceres S; Peña L; Crespo B; Illera JC Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359570 [TBL] [Abstract][Full Text] [Related]
95. Current research progress in targeted anti-angiogenesis therapy for osteosarcoma. Liu Y; Huang N; Liao S; Rothzerg E; Yao F; Li Y; Wood D; Xu J Cell Prolif; 2021 Sep; 54(9):e13102. PubMed ID: 34309110 [TBL] [Abstract][Full Text] [Related]
96. A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy. Navid F; Santana VM; Neel M; McCarville MB; Shulkin BL; Wu J; Billups CA; Mao S; Daryani VM; Stewart CF; Kunkel M; Smith W; Ward D; Pappo AS; Bahrami A; Loeb DM; Reikes Willert J; Rao BN; Daw NC Int J Cancer; 2017 Oct; 141(7):1469-1477. PubMed ID: 28631382 [TBL] [Abstract][Full Text] [Related]
97. Inhibition of Growth and Metastasis of Tumor in Nude Mice after Intraperitoneal Injection of Bevacizumab. Zhao ZX; Li X; Liu WD; Liu XZ; Wu SJ; Hu XH Orthop Surg; 2016 May; 8(2):234-40. PubMed ID: 27384733 [TBL] [Abstract][Full Text] [Related]
98. Antimetastatic Efficacy of the Combination of Caffeine and Valproic Acid on an Orthotopic Human Osteosarcoma Cell Line Model in Nude Mice. Igarashi K; Kawaguchi K; Kiyuna T; Murakami T; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Hoffman RM Anticancer Res; 2017 Mar; 37(3):1005-1011. PubMed ID: 28314258 [TBL] [Abstract][Full Text] [Related]
99. Imaging the inhibition by anti-β1 integrin antibody of lung seeding of single osteosarcoma cells in live mice. Kimura H; Tome Y; Momiyama M; Hayashi K; Tsuchiya H; Bouvet M; Hoffman RM Int J Cancer; 2012 Nov; 131(9):2027-33. PubMed ID: 22323248 [TBL] [Abstract][Full Text] [Related]
100. Effect of bevacizumab on angiogenesis and growth of canine osteosarcoma cells xenografted in athymic mice. Scharf VF; Farese JP; Coomer AR; Milner RJ; Taylor DP; Salute ME; Chang MN; Neal D; Siemann DW Am J Vet Res; 2013 May; 74(5):771-8. PubMed ID: 23627391 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]